Records containing: Neurofibromatosis 1
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-09-02Developing Novel Biomarkers of Plexiform Neurofibroma Tumor Burden
-
CLINICAL_TRIALS study record update · 2025-07-22iCanCope With NF: Innovating an Efficacious Digital Self-management and Transitional Care Program for Adolescents With Neurofibromatosis
-
CLINICAL_TRIALS study record update · 2025-06-17A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Ruvometinib Tablets (FCN-159 Tablets) in Pediatric Participants With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2025-05-08Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2025-03-30Innovation in the Treatment of Persistent Pain in Adults With Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope Mobile Application- Clinical Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-03-06A Randomized, Double-Blind, Placebo-Controlled, Multi-center Phase III Clinical Study to Evaluate the Efficacy and Safety of FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas
-
CLINICAL_TRIALS study record update · 2025-02-24Feasibility and Comparison Study of Home Blood Pressure Monitoring and Clinical Hypnosis in Children With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2025-02-21Dosing and Tolerability of Deoxycholic Acid Versus Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas
-
CLINICAL_TRIALS study record update · 2024-11-12A Multi-center, Open-label, Single-arm Phase I Dose-escalation and Phase II Dose-expansion Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2024-10-09Antioxidant Therapy With N-acetylcysteine for Motor Behavior and/or Learning in Children With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2024-10-01Prospective, One-arm, Phase II Clinical Study of Smeitinib Hydrosulfate Capsules for the Treatment of Patients With Type I Neurofibromatosis
-
CLINICAL_TRIALS study record update · 2024-10-01A Prospective, One-arm, Phase II Clinical Study of Smeitinib Hydrosulfate Capsules for the Treatment of Patients With Type I Neurofibromatosis After Surgery
-
CLINICAL_TRIALS study record update · 2024-09-19Incidence of Malignant Peripheral Nerve Sheath Tumors Development in Patients With Neurofibromatosis Type 1 Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas
-
CLINICAL_TRIALS study record update · 2024-07-26Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
-
CLINICAL_TRIALS study record update · 2024-06-11Pilot Study of Medication Adherence in Children, Adolescents, and Adults With Neurofibromatosis Type 1 (NF1) on Clinical Treatment Trials
-
CLINICAL_TRIALS study record update · 2024-04-23A Retrospective Study on Epidemiological Characteristics of Chinese NF1 Patients in Real World (PROMISE)
-
CLINICAL_TRIALS study record update · 2024-04-11Treatment of NF1-related Plexiform Neurofibroma With Trametinib; a Single Arm, Open-label Trial With the Goals of Volumetric Partial Remission and Pain Relief
-
CLINICAL_TRIALS study record update · 2024-03-22Systematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical Trial
-
CLINICAL_TRIALS study record update · 2023-12-26SARC031: A Phase 2 Trial of the MEK Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Combination With the mTOR Inhibitor Sirolimus for Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
-
CLINICAL_TRIALS study record update · 2023-09-22Preliminary Feasibility and Clinical Effectiveness of a Single-Session Intervention on the Neurocognitive Functioning of Children and Adolescents With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2023-08-30Neurofibromatosis (NF) Registry Portal Funded by Children's Tumor Foundation
-
CLINICAL_TRIALS study record update · 2023-08-30Medical Treatment of "High-Risk" Neurofibromas in Patients With Type 1 Neurofibromatosis: A Clinical Trial of Sequential Medical Therapies
-
CLINICAL_TRIALS study record update · 2023-05-31A Multi-center, Open-label, Single-arm Phase II Study to Evaluate the Efficacy and Safety of HL-085 in the Treatment of Adult Participants With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
-
CLINICAL_TRIALS study record update · 2022-08-09A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2a Study to Determine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Activity of NFX-179 Gel in Subjects With Cutaneous Neurofibromas
-
CLINICAL_TRIALS study record update · 2022-03-15Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1